CV Sciences Inc (CVSI)

[Wolf-man jack]

WQLF SAYS: You come on this board stating you are a part of a company with your made up company nic. If an individual was TRULY a owner of the company you claim to be a part of, it is not only unprofessional to pump your company and begging for CV SCIENCES, business on this message board and bashing TRUE shareholders , we find it ridiculous. No pun intended YQU Understand. YQU offer nothing beneficial to the Shareholders on this message board. In your latest bashing and personal attack post, you stated " YQU are so far off". First and foremost, they aren't my words, they are Ai's words. ai states $850,000 + (plus). Do you know what this refers to in Brazil 👌Have Mercy WQLF ahoooooo.

Dr. Joong J Fang Said: Extract Labs was offering to be acquired for $400.000 Cash. What they owe the bank is unknown, but it wouldn't have been much more considering CV SCIENCES would not have been in a position to take on too much more of their debt. Why didn't YQU answer Sleuth's post to you? Cat cut your tongue.


https://ir.cvsciences.com/press-releases/detail/231/cv-sciences-inc-enters-into-definitive-agreement-to

Ai Generated:

In November 2024, CV Sciences entered into a definitive Stock Purchase Agreement to acquire Extract Labs for $400,000 in cash plus $1 million in CV Sciences shares, plus potential earn-out consideration of up to $600,000. However, the agreement is currently in dispute after the sellers claimed they could not proceed due to a lack of bank consent.

Breakdown of the Original Agreement

Initial Consideration: The transaction structure included a $400,000 cash payment and $1,000,000 in CV Sciences common stock at closing.

Earn-out Provisions: Extract Labs was eligible to receive up to $600,000 in additional shares based on specific post-closing net revenue targets (e.g., earning $300,000 if net revenue reached $4,600,000).
Timeline: The acquisition was originally expected to close in the first quarter of 2025.

Current Status

In early 2025, the sellers indicated they could not move forward with the deal due to failing to secure necessary bank consent, leading to a purported termination of the stock purchase agreement. CV Sciences is currently disputing this termination and evaluating its legal options.